Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-04-02
2009-06-02
Woodward, Cherie M (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000
Reexamination Certificate
active
07541335
ABSTRACT:
Disclosed are compositions relating to the Nogo receptor (NgR) family as well as fragments, chimeras, and variants thereof. The invention provides polypeptides, nucleic acids, vectors, expression systems, and antibodies and antibody fragments related to the NgRs as well as uses thereof. Such uses include modulation neurite outgrowth in a subject and treatment of central nervous system disorders in a subject, as well as, methods of identifying and screening compounds that can be used for modulating neurite outgrowth in a subject or in treatment of central nervous system disorders in a subject.
REFERENCES:
patent: 2002/0012965 (2002-01-01), Strittmatter
patent: 2002/0077295 (2002-06-01), Strittmatter
patent: 2003/0113325 (2003-06-01), He et al.
patent: 2004/0029169 (2004-02-01), He et al.
patent: 2004/0259092 (2004-12-01), Barske et al.
patent: WO 01/51520 (2001-07-01), None
patent: WO 02/29059 (2002-04-01), None
patent: WO 03/018631 (2003-03-01), None
patent: WO 03/035687 (2003-05-01), None
Barton et al., EMBO J. Jul. 1, 2003;22(13):3291-3302.
He et al., Neuron. Apr. 24, 2003;38(2):177-185.
Domeniconi et al., Neuron. Jul. 18, 2002;35(2):283-290.
NCBI Blast Search—13 amino acid residues (315-327 of NgR2) run on Nov. 7, 2008.
UniProt Q9BZR6 (RNT4R—Human) (473 amino acid residues) (also known as NgR1), Accessed Nov. 7, 2008.
UniProt Q86UN3 (RTRL2—Human) (420 amino acid residues) (also known as NgR2). Accessed Nov. 7, 2008.
Ellezam et al., “Vaccination stimulates retinal ganglion cell regeneration in the adult optic nerve”Neurobiology of Disease12:1-10 (2003).
Grandpre et al., “Funcational analysis of nogo-66 and nogo receptor domains”Abstracts of the Society for Neuroscience27:670 (2001).
Venkatesh et al., “The nogo-66 receptor homolog ngr2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein”Jorunal of Neuroscience25:808-22 (2005).
Adams et al., “A role for syndecan-1 in coupling fascin spike formation by thrombospondin- 1”J. Cell Biol., 2001. 152(6):1169-82.
Bandtlow and Zirnnlerrnann, “Proteoglycans in the developing brain: new conceptual insights for old proteins.”Physiol. Rev., 2000. 80(4): 1267-90.
Barnett et al., “Signaling by glial cell line-derived neurotrophic factor (gdnf) requires heparan sulphate glycosaminoglycan.”J Cell Sci,2002. 11 5(23):4495-503.
Barton et al., “Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins.”EMBO J2003. 22(13):3291-302.
Berndt et al., “Cloning and characterization of human sytidccnn-3.”J Cell Biochem., 2001. 82(2):246-59.
Bowers et al., “Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers”Gene Ther., 2001. 8(2):111-20.
Bregman et al., “Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors.”Nature, 1995. 378(6556):498-501.
Brosamle et al., “Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment.”J. Neurosci., 2000. 20(21):8061-8.
Carey, “Syndecans: Multifunctional cell-surface co-receptors.”J. Biochem., 1997. 327(1):1-16.
Caroni and Schwab, “Antibody against myelin-associated inhibitor of neurite growth neutralizes non-permissive substrate properties of cns white matter.”Neuron, 1988. 1(1):85-96.
Chen et al., “Nogo-a is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1.”Nature, 2000. 403(6768):434-9.
Collins et al., “Sialic acid specificity of myelin-associated glycoprotein binding.”J. Biol. Chem., 1997. 272(2):1248-55.
DeBellard et al., “Myelin-associated glycoprotein inhibits axonal regeneration from a variety of neurons via interaction with a sialoglycoprotein.”Molecular and Cellular Neuroscience, 1996. 7:89-101.
Domeniconi et al., “Myelin-associated glycoprotein interacts with the nogo66 receptor to inhibit neurite outgrowth.”Neuron, 2002. 35(2):283-90.
Ethell et al., Ephb/syndecan-2 signaling in dendritic spine morphogenesis.Neuron, 2001. 31(6):1001-13.
Fournier et al., “Truncated soluble nogo receptor binds nogo-66 and blocks inhibition of axon growth by myelin.”J. Neurosci., 2002. 22(20):8876-83.
Fournier et al., “Identification of a receptor mediating nogo-66 inhibition of axonal regeneration.”Nature, 2001. 409(6818):341-6.
Fournier and Strittmatter, “Repulsive factors and axon regeneration in the cns.”Curr. Opin. Neurobiol., 2001. 11(1):89-94.
Giger et al., “Anatomy of rat semaphorin iii/collapsin-1 mrna expression and relationship to developing nerve tracts during neuroembryogenesis.”J Comp Neurol, 1996.375(3):318-92.
Giger et al., “Adenovirus-mediated gene transfer in neurons: construction and characterization of a vector for heterologous expression of the axonal cell adhesion molecule axonin-1.”J. Neurosci. Methods, 1997 1: 99-111.
Giger et al., “Anatomical distribution of the chemorepellent semaphorin iii/collapsin- 1 in the adult rat and human brain: Predominant expression in the olfactory-hippocampal pathway and the motor system.”J. Neurosci. Res., 1998. 1:27-42.
Giger et al., “Neuropilin-2 is a receptor for semaphorin iv: Insight into the structural basis of receptor function and specificity.”Neuron, 1998. 21:1074-1092.
Giger et al., “Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins.”Neuron, 2000. 25(1):29-41.
GrandPre et al., “Nogo-66 receptor antagonist peptide promotes axonal regeneration.”Nature, 2002. 417(6888):547-51.
GrandPre et al., “Identification of the nogo inhibitor of axon regeneration as a reticulon protein.”Nature, 2000. 403(6768):439-44.
Granes et al., “Ezrin links syndecan-2 to the cytoskeleton.”J. Cell Sci. 2000. 113( Pt 7):1267-76.
Hartmann and Maurer, “Proteoglycans in the nervous system—the quest for functional roles in vivo.”Matrix Biol., 2001. 20(1):23-35.
Heinegard and Sommarin, “Proteoglycans: an overview.”Methods Enzmol., 1987. 144:305-19.
Hileman et al., “Glycosaminoglycan-protein interactions: Definition of consensus sites in glycosaminoglycan binding proteins.”Bioessays, 1998. 20(2):156-67.
Hsueh and Sheng, “Regulated expression and subcellular localization of syndecan heparan sulfate proteoglycans and the syndecan-binding protein CASWLIN-2 during rat brain development.”J Neurosci., 1999. 19(17):7415-25.
Josephson et al., “Nogo-receptor gene activity: Cellular localization and developmental regulation of mRNA in mice and humans.”J Comp Neurol., 2002. 453:292-304.
Kaksonen et al., “Syndecan-3-deficient mice exhibit enhanced Itp and impaired hippocampus-dependent memory.”Mol Cell Neurosci., 2002. 21(1):158-72.
Kawai et al., “Mice expressing only monosialoganglioside gm3 exhibit lethal audiogenic seizures.”J. Biol. Chem, 2001. 276(10):6885-8.
Kelm et al., “Sialoadhesin, myelin-associated glycoprotein and cd22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily.”Current Biology, 1994. 4(11):965-72.
Kinnunen et al., “Heparan sulphate and HB-GAM (heparin-binding growth-associated molecule) in the development of the thalamocortical pathway of rat brain.”Eur J Neurosci., 1999. 11(2):491-502.
Kobe and Deisenhofer, “The leucine-rich repeat: a versatile binding motif.”TIBS, 19:415-420, Oct. 1994/CMW/Nov. 13, 2008.
Kobe and Kajava, “The leucine-rich repeat as a protein recognition motif.”Curr. Opin. Struct. Biol., 2001. 11:725-32.
Kolodkin et al., “Neuropilin is a semaphorin iii receptor.”Cell, 1997. 90(4):757-62.
Kolter et al., “Combinatorial ganglioside biosynthesis.”J. Biol.
Fish & Richardson P.C.
University of Rochester
Woodward Cherie M
LandOfFree
Nogo-receptors and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nogo-receptors and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nogo-receptors and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4063536